Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Appointed director
|
AIM ImmunoTech Inc. (HEB)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/13/2021 |
4/A
| Equels Thomas K (CEO & President) has filed a Form 4 on AIM ImmunoTech Inc.
Txns:
| Granted 21,552 shares
@ $1.16, valued at
$25k
|
|
06/25/2019 |
4/A
| EQUELS THOMAS K. (Exec. Vice Chairman/CEO/Pres.) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Bought 29,404 shares
@ $4.03, valued at
$118.5k
|
|
06/29/2017 |
4/A
| Equels Thomas K. (CEO / President) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Granted 14,212 options to buy
@ $0.49, valued at
$7k
|
|
06/29/2017 |
4/A
| Rodino Peter W. III (Exec Dir Govt Relations/Secrty) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Granted 6,632 options to buy
@ $0.49, valued at
$3.2k
|
|
06/29/2017 |
4/A
| Springate Wayne S. (Sr VP of Operations) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Granted 4,264 options to buy
@ $0.49, valued at
$2.1k
|
|
06/29/2017 |
4/A
| Pascale Adam (CFO) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Granted 4,738 options to buy
@ $0.49, valued at
$2.3k
|
|
06/26/2017 |
4/A
| Appelrouth Stewart (Director) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Granted 12,644 options to buy
@ $0.67, valued at
$8.5k
Granted 13,238 options to buy
@ $0.64, valued at
$8.5k
Granted 14,361 options to buy
@ $0.59, valued at
$8.5k
Granted 17,287 options to buy
@ $0.49, valued at
$8.5k
|
|
02/21/2017 |
4/A
| Springate Wayne S. (Sr VP of Operations) has filed a Form 4 on HEMISPHERX BIOPHARMA INC |
03/14/2016 |
4/A
| Equels Thomas K. (CEO,Pres,Exec Vice Chairman) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Bought 30,000 shares
@ $0.1564, valued at
$4.7k
Bought 10,000 shares
@ $0.1618, valued at
$1.6k
|
|
03/14/2016 |
4/A
| Equels Thomas K. (CEO,Pres,Exec Vice Chairman) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Bought 30,000 shares
@ $0.163, valued at
$4.9k
|
|
07/01/2010 |
4/A
| CARTER WILLIAM A (CEO) has filed a Form 4 on HEMISPHERX BIOPHARMA INC
Txns:
| Bought 500,000 options to buy
@ $0.66, valued at
$330k
|
|
|
|